Publications en collaboration avec des chercheurs de Hospital Universitario Virgen del Rocío (23)

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

2021

  1. Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 13

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2017

  1. An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis

    Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457

  2. Clinical and epidemiological differences between men and women with systemic sclerosis: A study in a Spanish systemic sclerosis cohort and literature review

    Clinical and Experimental Rheumatology, Vol. 35, pp. S89-S97

2016

  1. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 2, pp. 200-208

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

  2. Registry of the Spanish network for systemic sclerosis: Survival, prognostic factors, and causes of death

    Medicine (United States), Vol. 94, Núm. 43

2014

  1. Erratum: Health-related Internet use by lupus patients in southern Spain (Clin Rheumatol DOI: 10.1007/s10067-013-2395-z)

    Clinical Rheumatology

  2. Health-related Internet use by lupus patients in southern Spain

    Clinical Rheumatology, Vol. 33, Núm. 4, pp. 567-573

2012

  1. Association between -174 interleukin-6 gene polymorphism and biological response to rituximab in several systemic autoimmune diseases

    DNA and Cell Biology, Vol. 31, Núm. 9, pp. 1486-1491

  2. Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions

    Clinical and Experimental Rheumatology, Vol. 30, Núm. 6, pp. 905-911

  3. Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts

    Autoimmunity Reviews, Vol. 11, Núm. 5, pp. 357-364

  4. Influence of the IL6 gene in susceptibility to systemic sclerosis

    Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302

  5. Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status

    Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 6, pp. 789-800

2009

  1. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

    Clinical and Experimental Rheumatology

  2. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans

    Journal of Clinical Investigation, Vol. 119, Núm. 4, pp. 911-923

  3. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus

    Lupus, Vol. 18, Núm. 3, pp. 230-234

  4. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753